Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Pujol

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Revue De Pneumologie Clinique|May 25, 2006
[Is small cell lung cancer an orphan disease?]J L Pujol
Revue Des Maladies Respiratoires|September 4, 2018
[Small cell lung cancer and immuno-oncologic agents: End of the cisplatin - etoposide era?]J L Pujol, B Roch
Hrmagazine : on Human Resource Management|May 9, 1990
A vision for excellenceJ L Pujol, E Tudanger
Presse Medicale (Paris, France : 1983)|March 9, 1991
[Neoadjuvant chemotherapy of non-small cell bronchial cancers]J L Pujol, F B Michel
Revue Des Maladies Respiratoires|April 23, 2014
[One more word about the diagnostic. A metapsychological approach]J-L Pujol, J-P Mérel
Bulletin De L'Academie Nationale De Medecine|October 1, 1996
[Bronchial cancer: from epidemiology to treatment]F B Michel, J L Pujol
Revue Des Maladies Respiratoires|April 11, 2006
[Treatment of epithelial thymic tumours: towards a multidisciplinary management]W Jacot, X Quantin, J-L Pujol
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2015
Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et alJ-L Pujol, F Morin, G Zalcman, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 1995
Interleukin-1 alpha and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSFV Gautier, J L Pujol, F B Michel
Pathologie-Biologie|November 1, 1992
The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trialJ L Pujol, I Tabah, F B Michel
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Revue De Pneumologie Clinique|May 25, 2006
[Is small cell lung cancer an orphan disease?]J L Pujol
Revue Des Maladies Respiratoires|September 4, 2018
[Small cell lung cancer and immuno-oncologic agents: End of the cisplatin - etoposide era?]J L Pujol, B Roch
Hrmagazine : on Human Resource Management|May 9, 1990
A vision for excellenceJ L Pujol, E Tudanger
Presse Medicale (Paris, France : 1983)|March 9, 1991
[Neoadjuvant chemotherapy of non-small cell bronchial cancers]J L Pujol, F B Michel
Revue Des Maladies Respiratoires|April 23, 2014
[One more word about the diagnostic. A metapsychological approach]J-L Pujol, J-P Mérel
Bulletin De L'Academie Nationale De Medecine|October 1, 1996
[Bronchial cancer: from epidemiology to treatment]F B Michel, J L Pujol
Revue Des Maladies Respiratoires|April 11, 2006
[Treatment of epithelial thymic tumours: towards a multidisciplinary management]W Jacot, X Quantin, J-L Pujol
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2015
Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et alJ-L Pujol, F Morin, G Zalcman, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 1995
Interleukin-1 alpha and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSFV Gautier, J L Pujol, F B Michel
Pathologie-Biologie|November 1, 1992
The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trialJ L Pujol, I Tabah, F B Michel
Pageof 15